Agenus' (AGEN) CEO Garo Armen on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
Agenus Inc. (AGEN)
Last agenus inc. earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
agenusbio.com/investors
Company Research
Source: Seeking Alpha
Agenus' (AGEN) CEO Garo Armen on Q1 2019 Results - Earnings Call Transcript Agenus, Inc. (NASDAQ: AGEN Company Participants Jennifer Buell – Chief Operating Officer Garo Armen – Chairman and Chief Executive Officer Dhan Chand – Senior Scientist Bruno Lucidi – Chief Executive Officer-AgenTus, Cell Therapy Business Entity Christine Klaskin – Vice President of Finance Conference Call Participants Harshita Polishetty – B. Riley FBR Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Agenus First Quarter 2019 Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Dr. Jennifer Buell, Chief Operating Officer of Agenus. Dr. Buell, Please go ahead. Thank you, operator. Today’s call is being webcast and will be available on our website for replay. Before we start, we would like to remind you that this call will include forward-looking statements, including statements regarding our
Show less
Read more
Impact Snapshot
Event Time:
AGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGEN alerts
High impacting Agenus Inc. news events
Weekly update
A roundup of the hottest topics
AGEN
News
- Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 | CAGR of 3.9% [Yahoo! Finance]Yahoo! Finance
- SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant [Yahoo! Finance]Yahoo! Finance
- Agenus Inc. (NASDAQ: AGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Down 75%. Is Agenus Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
- Agenus announces reverse stock split of common stock [Seeking Alpha]Seeking Alpha
AGEN
Earnings
- 3/14/24 - Miss
AGEN
Analyst Actions
- 3/18/24 - HC Wainwright
AGEN
Sec Filings
- 4/8/24 - Form 4
- 4/5/24 - Form 8-K
- 4/1/24 - Form 4
- AGEN's page on the SEC website